We previously showed that high doses of TSLP increased the proliferation and production of normal human CD19+ PAX+ pro-B cells and low doses of TSLP maintained the survival of CRLF2 B-ALL cells [28,29]. Here, CRLF2 is linked to acute lymphoblastic leukemia.